JP2018501266A5 - - Google Patents

Download PDF

Info

Publication number
JP2018501266A5
JP2018501266A5 JP2017533569A JP2017533569A JP2018501266A5 JP 2018501266 A5 JP2018501266 A5 JP 2018501266A5 JP 2017533569 A JP2017533569 A JP 2017533569A JP 2017533569 A JP2017533569 A JP 2017533569A JP 2018501266 A5 JP2018501266 A5 JP 2018501266A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
independently
optionally substituted
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018501266A (ja
JP6523461B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2015/050930 external-priority patent/WO2016102776A1/en
Publication of JP2018501266A publication Critical patent/JP2018501266A/ja
Publication of JP2018501266A5 publication Critical patent/JP2018501266A5/ja
Application granted granted Critical
Publication of JP6523461B2 publication Critical patent/JP6523461B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533569A 2014-12-23 2015-12-22 17β−HSD1−阻害剤のプロドラッグ Active JP6523461B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20146150 2014-12-23
FI20146150 2014-12-23
PCT/FI2015/050930 WO2016102776A1 (en) 2014-12-23 2015-12-22 Prodrugs of 17.beta.-hsd1 -inhibitors

Publications (3)

Publication Number Publication Date
JP2018501266A JP2018501266A (ja) 2018-01-18
JP2018501266A5 true JP2018501266A5 (enExample) 2019-01-17
JP6523461B2 JP6523461B2 (ja) 2019-06-05

Family

ID=55221442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017533569A Active JP6523461B2 (ja) 2014-12-23 2015-12-22 17β−HSD1−阻害剤のプロドラッグ

Country Status (5)

Country Link
US (1) US10413557B2 (enExample)
EP (1) EP3237431B1 (enExample)
JP (1) JP6523461B2 (enExample)
CN (1) CN107207561B (enExample)
WO (1) WO2016102776A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3237430B1 (en) * 2014-12-23 2019-03-20 Forendo Pharma Ltd PRODRUGS OF 17ß -HSD1 -INHIBITORS
LT3634975T (lt) 2017-06-08 2024-06-25 Organon R&D Finland Ltd 15.beta.-[3-propanamido]-pakeisti estra-1,3,5(10)-trien-17-onų 17-oksimai, skirti 17.beta.-hidroksisteroidų dehidrogenazių slopinimui
WO2023122075A1 (en) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof
WO2025185710A1 (zh) * 2024-03-08 2025-09-12 长春金赛药业有限责任公司 17β-HSD1抑制剂化合物、药物组合物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2000125533A (ru) 1998-03-11 2002-10-20 Эндорешерш, Инк. (Ca) Ингибиторы 17-бета-гидроксистероиддегидрогеназ 5 и 3 типа и способы их применения
DE69935335T2 (de) 1998-08-07 2007-11-22 Novartis Vaccines and Diagnostics, Inc., Emeryville Pyrazole als modulatoren des östrogenrezeptors
GB9929302D0 (en) 1999-12-11 2000-02-02 Univ Cardiff Benzyl tetralins compositions and uses thereof
AU2002326823B2 (en) 2001-09-06 2005-12-15 Merck Sharp & Dohme Corp. 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
ES2347643T3 (es) 2001-10-17 2010-11-03 Schering Corporation Piperin- y piperazinacetamidas como inhibidores de 17beta hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades dependientes de androgenos.
US6750248B2 (en) 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
DE60332862D1 (de) 2002-11-18 2010-07-15 Schering Corp 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen
CN1744930A (zh) 2002-12-17 2006-03-08 先灵公司 治疗雄激素依赖性疾病的3型17β-羟基类固醇脱氢酶抑制剂
US7015211B2 (en) 2003-03-21 2006-03-21 Yale University 15α-substituted estradiol carboxylic acid esters as locally active estrogens
GB0306718D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
US7465739B2 (en) 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7754709B2 (en) 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
US8088758B2 (en) 2003-11-12 2012-01-03 Abbott Products Gmbh 17β-hydroxysteroid dehydrogenase type I inhibitors
TWI331154B (en) 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
DE102004032673A1 (de) 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1
DE102004032674A1 (de) 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
AU2006251154B2 (en) 2005-05-26 2012-06-28 Solvay Pharmaceuticals Gmbh 17beta-HSD1 and STS inhibitors
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
RU2469042C2 (ru) 2006-09-19 2012-12-10 Зольвай Фармасьютиклз Гмбх Терапевтически активные триазолы и их использование
CN101568547B (zh) 2006-11-30 2014-06-25 索尔瓦药物有限公司 作为17βHSD抑制剂的被取代的雌三烯衍生物
BR112015031846A8 (pt) * 2013-06-25 2018-03-06 Forendo Pharma Ltd derivados de estratrientiazol, seus usos, e composição farmacêutica
US9850272B2 (en) 2013-06-25 2017-12-26 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
TW201512215A (zh) 2013-06-25 2015-04-01 Forendo Pharma Ltd 治療活性雌三烯噻唑衍生物
EP3237430B1 (en) * 2014-12-23 2019-03-20 Forendo Pharma Ltd PRODRUGS OF 17ß -HSD1 -INHIBITORS

Similar Documents

Publication Publication Date Title
EA201170096A1 (ru) Замещенные производные пиримидона
JP2016506958A5 (enExample)
JP2017521436A5 (enExample)
JP2019104748A5 (enExample)
JP2017511357A5 (enExample)
RU2020110780A (ru) Ингибитор fgfr и его медицинское применение
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
JP2016503799A5 (enExample)
PH12016502154A1 (en) Pyridazonine herbicides
JP2016536364A5 (enExample)
JP2016505614A5 (enExample)
EA201591429A1 (ru) 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена
TR201909694T4 (tr) Janus kinaz (jak) inhibitörleri.
EA201591703A1 (ru) Замещенные 2-азабициклы и их применение в качестве модуляторов рецепторов орексина
JP2013537203A5 (enExample)
PH12012501773A1 (en) Arylethynyl derivatives
JP2014526533A5 (enExample)
UA117151C2 (uk) N-ациліміногетероциклічні сполуки
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
RU2021109549A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2008505194A5 (enExample)
JP2015535839A5 (enExample)
JP2014510147A5 (enExample)
JP2015530408A5 (enExample)